Biospring Partners

Abzena is a biologics research partner. They provide biologic and ADC products from concept to clinic. They develop biologics and bioconjugates, and provides the solutions in integrated early discovery to mid-phase biotherapeutic and bioconjugation drug development and manufacturing in the biopharmaceutical industry.

Kiniciti is a new Welsh, Carson, Anderson & Stowe platform established to partner with companies that have the potential to transform the cell and gene therapy ecosystem and deliver the promise of these therapies to impact patients’ lives. Bringing novel treatments to the patients who need them most — in an economically viable way — is too often crippled by persistent bottlenecks, constraints and inefficiencies in the development, manufacturing and delivery of those innovations

ixlayer is an industry leader in the health-tech ecosystem, providing innovative solutions for enabling health systems, payors, biopharma, and health-focused companies to offer health testing in a virtual environment. The ixlayer platform delivers end-to-end solutions for the technical, security, regulatory, and user experience components of complex health testing. As the industry shifts to remote and virtual care options, ixlayer is powering patient engagement and preventative health strategies through virtual health testing, at scale. The ixlayer solution can be added to existing patient engagement platforms and patient portals to enable real time health and wellness lab testing. Founded in 2018, ixlayer currently supports millions of patients and has launched hundreds of testing programs for large organizations, health systems and every level of the government.

Abzena is a biologics research partner. They provide biologic and ADC products from concept to clinic. They develop biologics and bioconjugates, and provides the solutions in integrated early discovery to mid-phase biotherapeutic and bioconjugation drug development and manufacturing in the biopharmaceutical industry.